Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 8/20/19 → 2/6/27 |
Financiación
- Eisai Incorporated: 1.180.760,00 US$
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
- Jicha, Gregory (PI)